SlideShare ist ein Scribd-Unternehmen logo
1 von 8
Cystic Fibrosis


  By: Michael Crudele, William
  Foschi, Gabby Battagila
Cystic fibrosis
 Genetic Disorder
 Hereditary
 Causes very thick mucus to form in
  respiratory and digestive system
 No cure
Symptoms
 Salty skin
 Under average growth and development
  despite healthy diet
 Persistent coughing
 Shortness of breath
 Frequent lung infections
 Digestive related problems: diabetes,
  pancreatitis, and malnutrition
Causes
 Genetic mutation
 Most common mutation is
  ΔF508. Deletes 3 amino
  acids along the CFTR gene
 The mutation is an
  autosomal recessive gene     Purple: Unaffected Carriers
                               Blue: Unaffected
 The gene will then produce   Red: Affected

  a bad CFTR protein
Causes (Continued)
   The CFTR gene is located towards the
    bottom of the larger half of the chromosome
    (q31.2)
   The ΔF508 results in a CFTR protein that is
    missing a fold and cannot complete its function
    as a pump to balance chloride, iodide and
    other chemicals inside and outside the cells
   These chemicals then will cause very thick,
    nutrient-rich mucus to form which lets bacteria
    thrive
Treatment and Prognosis for CF
      Machines are made to shake mucus loose
       by pounding the chest and back to help
       problems in the lungs
      Antibiotics and anti-inflammatory
       medicines are used to help treat and
       prevent lung infections
      Well balanced and high calorie meals are
       used to help nutritional problems
      Vitamins are taken as well as a feeding
       tube to provide nutrients for the patient
       while sleeping
CF’s effect in society
 CF affects about 30,000 people in the U.S.
  and about 70,000 world wide
 It is most common to find CF in
  Caucasians; about 1 in every 3,000 will
  have CF
 Patients diagnosed with CF are having
  dramatic increases in lifespan; it is now
  near 30-40, whereas patients in the 1950’s
  would most likely not live past 12
Bibliography
   Childers M, Eckel G, Himmel A, Caldwell J (2007). "A new model of cystic fibrosis
    pathology: lack of transport of glutathione and its thiocyanate conjugates". Medical
    Hypotheses 68 (1):
   Rowe SM, Miller S, Sorscher EJ (May 2005). "Cystic fibrosis". The New England
    Journal of Medicine 352 (19): 1992–2001
   "About Cystic Fibrosis." Cystic Fibrosis Foundation. Cystic Fibrosis Foundation, n.d.
    Web. 18 Dec. 2012.

   "Cystic Fibrosis." Genetics Home Reference. U.S. Department of Health & Human
    Services, 17 Dec. 2012. Web. 18 Dec. 2012.

   "How Is Cystic Fibrosis Treated?" National Heart Lung and Blood Institute. U.S.
    Department of Health & Human Services, 01 June 2011. Web. 18 Dec. 2012.
    Signs and Symptoms of Cystic Fibrosis. Digital image. National Heart Lung and Blood
    Institute. U.S. Department of Health & Human Services, 01 June 2011. Web. 18 Dec.
    2012.

   "Treatments." Cystic Fibrosis Foundation. Cystic Fibrosis Foundation, n.d. Web. 18
    Dec. 2012.

   "What Are the Signs and Symptoms of Cystic Fibrosis?" National Heart Lung and
    Blood Institute. U.S. Department of Health & Human Services, 01 June 2011. Web.
    18 Dec. 2012.

Weitere ähnliche Inhalte

Was ist angesagt?

Cystic fibrosis
Cystic fibrosisCystic fibrosis
Cystic fibrosis
sangita8
 
channelopathies in Cystic fibrosis
channelopathies in Cystic fibrosischannelopathies in Cystic fibrosis
channelopathies in Cystic fibrosis
flora786
 
Cystic fibrosis presentation
Cystic fibrosis presentationCystic fibrosis presentation
Cystic fibrosis presentation
joeyprince
 
Cystic fibrosis presentation
Cystic fibrosis presentationCystic fibrosis presentation
Cystic fibrosis presentation
parulshrestha
 
Cystic fibrosis- Ashley Verbeek
Cystic fibrosis- Ashley VerbeekCystic fibrosis- Ashley Verbeek
Cystic fibrosis- Ashley Verbeek
Ashley Verbeek
 

Was ist angesagt? (20)

Cystic Fibrosis
Cystic FibrosisCystic Fibrosis
Cystic Fibrosis
 
cystic fibrosis
cystic fibrosiscystic fibrosis
cystic fibrosis
 
Cystic Fibrosis
Cystic FibrosisCystic Fibrosis
Cystic Fibrosis
 
Cystic fibrosis
Cystic fibrosisCystic fibrosis
Cystic fibrosis
 
Cystic fibrosis[1]
Cystic fibrosis[1]Cystic fibrosis[1]
Cystic fibrosis[1]
 
channelopathies in Cystic fibrosis
channelopathies in Cystic fibrosischannelopathies in Cystic fibrosis
channelopathies in Cystic fibrosis
 
CYSTIC FIBROSIS
CYSTIC FIBROSISCYSTIC FIBROSIS
CYSTIC FIBROSIS
 
Cystic fibrosis presentation
Cystic fibrosis presentationCystic fibrosis presentation
Cystic fibrosis presentation
 
Cystic fibrosis
Cystic fibrosisCystic fibrosis
Cystic fibrosis
 
Cystic fibrosis
Cystic fibrosisCystic fibrosis
Cystic fibrosis
 
Cystic fibrosis
Cystic fibrosisCystic fibrosis
Cystic fibrosis
 
Cystic fibrosis presentation
Cystic fibrosis presentationCystic fibrosis presentation
Cystic fibrosis presentation
 
Cystic fibrosis
Cystic fibrosisCystic fibrosis
Cystic fibrosis
 
Cystic fibrosis
Cystic fibrosisCystic fibrosis
Cystic fibrosis
 
Cystic Fibrosis. GIT Manifestations. Diagnosis. Treatment
Cystic Fibrosis. GIT Manifestations. Diagnosis. TreatmentCystic Fibrosis. GIT Manifestations. Diagnosis. Treatment
Cystic Fibrosis. GIT Manifestations. Diagnosis. Treatment
 
Cystic fibrosis
Cystic fibrosisCystic fibrosis
Cystic fibrosis
 
Cystic fibrosis of the GIT
Cystic fibrosis of the GIT Cystic fibrosis of the GIT
Cystic fibrosis of the GIT
 
Cysticfibrosis
CysticfibrosisCysticfibrosis
Cysticfibrosis
 
Cystic Fibrosis
Cystic FibrosisCystic Fibrosis
Cystic Fibrosis
 
Cystic fibrosis- Ashley Verbeek
Cystic fibrosis- Ashley VerbeekCystic fibrosis- Ashley Verbeek
Cystic fibrosis- Ashley Verbeek
 

Ähnlich wie Cystic fibrosis

Cystic FibrosisCreated By Tammy Wagner, Karen Byfield, Sherry.docx
Cystic FibrosisCreated By Tammy Wagner, Karen Byfield, Sherry.docxCystic FibrosisCreated By Tammy Wagner, Karen Byfield, Sherry.docx
Cystic FibrosisCreated By Tammy Wagner, Karen Byfield, Sherry.docx
alanrgibson41217
 
Purification & Rejuvenation Public Lecture
Purification & Rejuvenation Public LecturePurification & Rejuvenation Public Lecture
Purification & Rejuvenation Public Lecture
DrConley
 

Ähnlich wie Cystic fibrosis (12)

Genetic Disorder
Genetic DisorderGenetic Disorder
Genetic Disorder
 
Cystic FibrosisCreated By Tammy Wagner, Karen Byfield, Sherry.docx
Cystic FibrosisCreated By Tammy Wagner, Karen Byfield, Sherry.docxCystic FibrosisCreated By Tammy Wagner, Karen Byfield, Sherry.docx
Cystic FibrosisCreated By Tammy Wagner, Karen Byfield, Sherry.docx
 
Bio viva-for-microsoft-avi3.pptx
Bio viva-for-microsoft-avi3.pptxBio viva-for-microsoft-avi3.pptx
Bio viva-for-microsoft-avi3.pptx
 
Sickle Cell Anemia by Mohammed kareem
Sickle Cell Anemia by Mohammed kareemSickle Cell Anemia by Mohammed kareem
Sickle Cell Anemia by Mohammed kareem
 
The Truth about Cystic Fibrosis
The Truth about Cystic FibrosisThe Truth about Cystic Fibrosis
The Truth about Cystic Fibrosis
 
Diet,Obesity,Chronic Disease
 Diet,Obesity,Chronic Disease Diet,Obesity,Chronic Disease
Diet,Obesity,Chronic Disease
 
The Case of Cystic Fibrosis in Australia
The Case of Cystic Fibrosis in AustraliaThe Case of Cystic Fibrosis in Australia
The Case of Cystic Fibrosis in Australia
 
Cystic fibrosis
Cystic fibrosisCystic fibrosis
Cystic fibrosis
 
Purification & Rejuvenation Public Lecture
Purification & Rejuvenation Public LecturePurification & Rejuvenation Public Lecture
Purification & Rejuvenation Public Lecture
 
Dag Andersson - CEO Diaverum, Chronic Diseases: The Everyday Epidemic
Dag Andersson - CEO Diaverum,  Chronic Diseases: The Everyday EpidemicDag Andersson - CEO Diaverum,  Chronic Diseases: The Everyday Epidemic
Dag Andersson - CEO Diaverum, Chronic Diseases: The Everyday Epidemic
 
19 Cystic fibrosis-nnn.pptx
19 Cystic fibrosis-nnn.pptx19 Cystic fibrosis-nnn.pptx
19 Cystic fibrosis-nnn.pptx
 
Dr Ashoo Grover
Dr Ashoo GroverDr Ashoo Grover
Dr Ashoo Grover
 

Kürzlich hochgeladen

Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
MateoGardella
 

Kürzlich hochgeladen (20)

Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 

Cystic fibrosis

  • 1. Cystic Fibrosis By: Michael Crudele, William Foschi, Gabby Battagila
  • 2. Cystic fibrosis  Genetic Disorder  Hereditary  Causes very thick mucus to form in respiratory and digestive system  No cure
  • 3. Symptoms  Salty skin  Under average growth and development despite healthy diet  Persistent coughing  Shortness of breath  Frequent lung infections  Digestive related problems: diabetes, pancreatitis, and malnutrition
  • 4. Causes  Genetic mutation  Most common mutation is ΔF508. Deletes 3 amino acids along the CFTR gene  The mutation is an autosomal recessive gene Purple: Unaffected Carriers Blue: Unaffected  The gene will then produce Red: Affected a bad CFTR protein
  • 5. Causes (Continued)  The CFTR gene is located towards the bottom of the larger half of the chromosome (q31.2)  The ΔF508 results in a CFTR protein that is missing a fold and cannot complete its function as a pump to balance chloride, iodide and other chemicals inside and outside the cells  These chemicals then will cause very thick, nutrient-rich mucus to form which lets bacteria thrive
  • 6. Treatment and Prognosis for CF  Machines are made to shake mucus loose by pounding the chest and back to help problems in the lungs  Antibiotics and anti-inflammatory medicines are used to help treat and prevent lung infections  Well balanced and high calorie meals are used to help nutritional problems  Vitamins are taken as well as a feeding tube to provide nutrients for the patient while sleeping
  • 7. CF’s effect in society  CF affects about 30,000 people in the U.S. and about 70,000 world wide  It is most common to find CF in Caucasians; about 1 in every 3,000 will have CF  Patients diagnosed with CF are having dramatic increases in lifespan; it is now near 30-40, whereas patients in the 1950’s would most likely not live past 12
  • 8. Bibliography  Childers M, Eckel G, Himmel A, Caldwell J (2007). "A new model of cystic fibrosis pathology: lack of transport of glutathione and its thiocyanate conjugates". Medical Hypotheses 68 (1):  Rowe SM, Miller S, Sorscher EJ (May 2005). "Cystic fibrosis". The New England Journal of Medicine 352 (19): 1992–2001  "About Cystic Fibrosis." Cystic Fibrosis Foundation. Cystic Fibrosis Foundation, n.d. Web. 18 Dec. 2012.  "Cystic Fibrosis." Genetics Home Reference. U.S. Department of Health & Human Services, 17 Dec. 2012. Web. 18 Dec. 2012.  "How Is Cystic Fibrosis Treated?" National Heart Lung and Blood Institute. U.S. Department of Health & Human Services, 01 June 2011. Web. 18 Dec. 2012. Signs and Symptoms of Cystic Fibrosis. Digital image. National Heart Lung and Blood Institute. U.S. Department of Health & Human Services, 01 June 2011. Web. 18 Dec. 2012.  "Treatments." Cystic Fibrosis Foundation. Cystic Fibrosis Foundation, n.d. Web. 18 Dec. 2012.  "What Are the Signs and Symptoms of Cystic Fibrosis?" National Heart Lung and Blood Institute. U.S. Department of Health & Human Services, 01 June 2011. Web. 18 Dec. 2012.